Key Developments: Immuron Ltd (IMC.AX)
0.00AUD
18 Jun 2013
$-0.00 (-25.00%)
$0.00
$0.00
$0.00
$0.00
250,000
783,919
$0.02
$0.00
Latest Key Developments (Source: Significant Developments)
Immuron Ltd Announces Ownership Interest Of Hadasit Medical Research Services & Development Ltd
Immuron Ltd announced that Hadasit Medical Research Services & Development Ltd has a holding interest of 46,966,139 ordinary shares representing 19.99% of issued share capital of the Company. Earlier Hadasit Medical Research Services & Development Ltd had an interest of 5.71% of issued share capital of the Company. Full Article
Immuron Ltd Announces Holding Interest Of Capital Concerns Pty Ltd
Immuron Ltd announced that Capital Concerns Pty Ltd (lLogue Family Super Fund) has an interest of 54,627,723 ordinary shares, which represents 5.38% of voting power in the Company. Full Article
Immuron Ltd Announces Holding Interest Of Grandlodge Pty Ltd
Immuron Ltd announced that Grandlodge Pty Ltd has an interest of 168,326,929 ordinary shares, which represents 16.56% of voting power in the Company. Full Article
Immuron Ltd Announces Issuance Of Shares
Immuron Ltd announced the issuance of 94,638,844 fully paid ordinary IMC shares at a total consideration of AUD 283,916.30 to eligible subscribers of the Renounceable Rights Issue as detailed in the prospectus announced to the ASX on March 27, 2013; as well as the issuance of 507,247,519 fully paid ordinary IMC shares at a total consideration of AUD 1,521,742.56 to the Sub-Underwriters of the Renounceable Rights Issue in accordance with the Underwriting Agreement and Prospectus dated March 27, 2013. Full Article
Immuron Ltd Announces Renounceable Pro-Rata Rights Issue Closure, Acceptances and Shortfall
Immuron Ltd announced that the recent renounceable rights issue offer made pursuant to the Prospectus dated March 27, 2013 to raise approximately AUD 1.9 million (before expenses) on the basis of three new fully paid shares in the Company for every two fully paid Shares held at an issue price of AUD 0.003 (the Rights Issue), closed on April 29, 2013. The Company advised that it has received entitlement acceptances in respect of 88,641,762 shares. Eligible Shareholders also subscribed for a further 5,997,082 in additional oversubscribed new shares under the shortfall available. The total funds received from shareholders totalled AUD 283,917. This provides a remaining shortfall of 526,631,242 shares. Full Article
Immuron Ltd Announces Underwritten Renounceable Rights Issue
Immuron Ltd announced that it is undertaking a fully underwritten renounceable pro-rata rights offer to the Company’s shareholders (the Offer). The Offer is open to all eligible shareholders of the Company who are on the share register as on April 08, 2013 ( the Record Date) and who have a registered address in Australia or New Zealand. Under the Offer, the Company will make an offer to all eligible shareholders of three fully paid New Shares for every two fully paid shares held as at the Record Date at a price of 0.3 of a cent ($0.003) per share. In addition to the rights issue, eligible shareholders will have the opportunity to also participate in a Top Up Offer if there is a shortfall in the Rights Offer. The offer is fully underwritten by Patersons Securities Limited and will be offered pursuant to a prospectus lodged by the Company. The rights issue will result in the issue of approximately 621,270,086 fully paid shares and raise $1,863,810, before the costs of the issue. Full Article
Immuron Ltd Announces No Dividend For H1 2013
Immuron Ltd announced that no dividend has been declared for the first half of 2013 (half year ended December 31, 2012). Full Article
Immuron Ltd Announces Resignation of Chief Executive Officer
Immuron Ltd announced that its Chief Executive Officer and Managing Director, Mr. Joe Baini, will resign from these roles effective from February 28, 2013 due to personal circumstances and the need for him to devote time to these. Mr. Amos Meltzer, Immuron’s Vice President, Business Development, will assume the role of interim CEO. Full Article
Immuron Ltd Announces Change Of Chairman
Immuron Ltd announced that Professor Colin Chapman is stepping down as non-executive Chairman and Board member due to personal commitments. Dr. Roger Aston has been appointed non-executive Chairman. Full Article
Immuron Ltd Declares No FY 2011/2012 Final Dividend
Immuron Ltd announced that no dividends were paid or declared during fiscal year 2011/2012. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
